S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   360.13 (-2.76%)
AAPL   141.98 (-2.33%)
MSFT   283.57 (-3.60%)
FB   340.82 (-3.61%)
GOOGL   2,717.23 (-3.69%)
TSLA   777.67 (-1.73%)
AMZN   3,319.98 (-2.52%)
NVDA   207.08 (-4.40%)
BABA   152.06 (+1.25%)
NIO   35.22 (-4.22%)
CGC   14.20 (-3.47%)
GE   105.85 (+0.47%)
MU   73.24 (-2.58%)
AMD   101.50 (-6.16%)
T   27.28 (-0.44%)
F   14.32 (+1.13%)
ACB   6.84 (+7.04%)
DIS   174.41 (-2.16%)
PFE   43.08 (-1.12%)
BA   218.75 (-2.41%)
AMC   37.19 (-5.37%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   360.13 (-2.76%)
AAPL   141.98 (-2.33%)
MSFT   283.57 (-3.60%)
FB   340.82 (-3.61%)
GOOGL   2,717.23 (-3.69%)
TSLA   777.67 (-1.73%)
AMZN   3,319.98 (-2.52%)
NVDA   207.08 (-4.40%)
BABA   152.06 (+1.25%)
NIO   35.22 (-4.22%)
CGC   14.20 (-3.47%)
GE   105.85 (+0.47%)
MU   73.24 (-2.58%)
AMD   101.50 (-6.16%)
T   27.28 (-0.44%)
F   14.32 (+1.13%)
ACB   6.84 (+7.04%)
DIS   174.41 (-2.16%)
PFE   43.08 (-1.12%)
BA   218.75 (-2.41%)
AMC   37.19 (-5.37%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   360.13 (-2.76%)
AAPL   141.98 (-2.33%)
MSFT   283.57 (-3.60%)
FB   340.82 (-3.61%)
GOOGL   2,717.23 (-3.69%)
TSLA   777.67 (-1.73%)
AMZN   3,319.98 (-2.52%)
NVDA   207.08 (-4.40%)
BABA   152.06 (+1.25%)
NIO   35.22 (-4.22%)
CGC   14.20 (-3.47%)
GE   105.85 (+0.47%)
MU   73.24 (-2.58%)
AMD   101.50 (-6.16%)
T   27.28 (-0.44%)
F   14.32 (+1.13%)
ACB   6.84 (+7.04%)
DIS   174.41 (-2.16%)
PFE   43.08 (-1.12%)
BA   218.75 (-2.41%)
AMC   37.19 (-5.37%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   360.13 (-2.76%)
AAPL   141.98 (-2.33%)
MSFT   283.57 (-3.60%)
FB   340.82 (-3.61%)
GOOGL   2,717.23 (-3.69%)
TSLA   777.67 (-1.73%)
AMZN   3,319.98 (-2.52%)
NVDA   207.08 (-4.40%)
BABA   152.06 (+1.25%)
NIO   35.22 (-4.22%)
CGC   14.20 (-3.47%)
GE   105.85 (+0.47%)
MU   73.24 (-2.58%)
AMD   101.50 (-6.16%)
T   27.28 (-0.44%)
F   14.32 (+1.13%)
ACB   6.84 (+7.04%)
DIS   174.41 (-2.16%)
PFE   43.08 (-1.12%)
BA   218.75 (-2.41%)
AMC   37.19 (-5.37%)
LON:RB

Reckitt Benckiser Group Share Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
5,854
6,783
52-Week Range N/A
Volume1.14 million shs
Average Volume252,769 shs
Market Capitalization£48.36 billion
P/E Ratio40.79
Dividend Yield2.69%
BetaN/A

Receive RB News and Ratings via Email

Sign-up to receive the latest news and ratings for Reckitt Benckiser Group and its competitors with MarketBeat's FREE daily newsletter.


Reckitt Benckiser Group logo

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; footcare and footwear products; sore throat medications; and women's beauty products under the Nurofen, Scholl, Strepsils, and Veet brand. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet bowl cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as infant and child nutrition products under the Enfamil and Nutramigen brands. It operates in the United States, Canada, Europe, Russia/CIS, Turkey, Israel, Australia, New Zealand, and internationally. The company was founded in 1823 and is headquartered in Slough, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Personal Products
Sub-Industry
N/A
CIK
N/A
Employees
37,756
Year Founded
N/A

Sales & Book Value

Annual Sales
£13.99 billion
Book Value
GBX 1,280.90 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
£48.36 billion
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.89 out of 5 stars

Analyst Opinion: 3.3Community Rank: 4.7Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












Reckitt Benckiser Group (LON:RB) Frequently Asked Questions

Is Reckitt Benckiser Group a buy right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Reckitt Benckiser Group in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Reckitt Benckiser Group stock.
View analyst ratings for Reckitt Benckiser Group
or view top-rated stocks.

What stocks does MarketBeat like better than Reckitt Benckiser Group?

Wall Street analysts have given Reckitt Benckiser Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Reckitt Benckiser Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How often does Reckitt Benckiser Group pay dividends? What is the dividend yield for Reckitt Benckiser Group?

Reckitt Benckiser Group announced a dividend on Wednesday, February 24th. Shareholders of record on Thursday, May 6th will be paid a dividend of GBX 101.60 per share on Monday, June 14th. This represents a dividend yield of 1.7%. The ex-dividend date of this dividend is Thursday, May 6th. This is an increase from Reckitt Benckiser Group's previous dividend of GBX 73. The official announcement can be seen at this link.
View Reckitt Benckiser Group's dividend history
.

Is Reckitt Benckiser Group a good dividend stock?

Reckitt Benckiser Group pays an annual dividend of GBX 175 per share and currently has a dividend yield of 2.69%. The dividend payout ratio of Reckitt Benckiser Group is 105.23%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Reckitt Benckiser Group's dividend history.

What price target have analysts set for RB?

11 equities research analysts have issued 1 year target prices for Reckitt Benckiser Group's shares. Their forecasts range from GBX 5,400 to GBX 9,500. On average, they anticipate Reckitt Benckiser Group's stock price to reach GBX 7,197.27 in the next year.
View analysts' price targets for Reckitt Benckiser Group
or view top-rated stocks among Wall Street analysts.

Who are Reckitt Benckiser Group's key executives?

Reckitt Benckiser Group's management team includes the following people:
  • Mr. Laxman Narasimhan, Group CEO & Exec. Director (Age 53, Pay $5.12M)
  • Mr. Jeffrey Carr, Group CFO & Exec. Director (Age 60)
  • Mr. Richard Joyce, Sr. VP of Investor Relations
  • Mr. Rupert Bondy, Sr. VP, Gen. Counsel & Company Sec. (Age 59)
  • Mr. Ranjay Radhakrishnan, Chief HR Officer
  • Mr. Aditya Sehgal, Pres of Nutrition & Pres of China & E-RB
  • Mr. Kris Licht, Pres of Health & Global Chief Customer Officer
  • Mr. John Dawson, Sr. VP of Investor Relations
  • Mr. Miguel Veiga-Pestana, Head of Corp. Affairs & Chief Sustainability Officer
  • Mr. Sami Naffakh, Chief Supply Officer

Who are some of Reckitt Benckiser Group's key competitors?

What other stocks do shareholders of Reckitt Benckiser Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reckitt Benckiser Group investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Prudential (PRU), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), British American Tobacco (BATS), NIC (EGOV), Vodafone Group (VOD) and Aegean Marine Petroleum Network (ANW).

What is Reckitt Benckiser Group's stock symbol?

Reckitt Benckiser Group trades on the London Stock Exchange (LON) under the ticker symbol "RB."

How do I buy shares of Reckitt Benckiser Group?

Shares of RB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does Reckitt Benckiser Group make?

Reckitt Benckiser Group has a market capitalization of £0.00 and generates £13.99 billion in revenue each year.

How many employees does Reckitt Benckiser Group have?

Reckitt Benckiser Group employs 37,756 workers across the globe.

What is Reckitt Benckiser Group's official website?

The official website for Reckitt Benckiser Group is www.rb.com.

Where are Reckitt Benckiser Group's headquarters?

Reckitt Benckiser Group is headquartered at 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom.

How can I contact Reckitt Benckiser Group?

Reckitt Benckiser Group's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The company can be reached via phone at +44-1753-217800.


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.